BMS’ Sprycel Is Latest CDF Drug To Get NICE Clearance For Routine NHS Use
Executive Summary
NICE has given the go-ahead for routine NHS commissioning of seven cancer drugs/indications that were listed on the Cancer Drugs Fund before it was overhauled earlier this year. A total of 35 product indications are up for reappraisal under the program.